44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)

• Yuan Liu,
• Dylan Martini,
• T Anders Olsen,
• Subir Goyal,
• Sean Evans,
• Benjamin Magod,
• Jacqueline Brown,
• Lauren Yantorni,
• Greta Russler,
• Sarah Caulfield,
• Jamie Goldman,
• Bassel Nazha,
• Wayne Harris,
• Viraj Master,
• Omer Kucuk

Affiliations

Yuan Liu

2Emory University, Atlanta, GA, USA

Dylan Martini

1Emory University School of Medicine, Atlanta, GA, USA

T Anders Olsen

1Emory University School of Medicine, Atlanta, GA, USA

Subir Goyal

2Emory University, Atlanta, GA, USA

Sean Evans

1Emory University School of Medicine, Atlanta, GA, USA

Benjamin Magod

1Emory University School of Medicine, Atlanta, GA, USA

Jacqueline Brown

1Emory University School of Medicine, Atlanta, GA, USA

Lauren Yantorni

3Winship Cancer Institute of Emory University, Atlanta, GA, USA

Greta Russler

3Winship Cancer Institute of Emory University, Atlanta, GA, USA

Sarah Caulfield

1Emory University School of Medicine, Atlanta, GA, USA

Jamie Goldman

1Emory University School of Medicine, Atlanta, GA, USA

Bassel Nazha

1Emory University School of Medicine, Atlanta, GA, USA

Wayne Harris

1Emory University School of Medicine, Atlanta, GA, USA

Viraj Master

1Emory University School of Medicine, Atlanta, GA, USA

Omer Kucuk

1Emory University School of Medicine, Atlanta, GA, USA